Literature DB >> 16163535

D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats.

Abesh Kumar Bhattacharjee1, Lisa Chang, Ho-Joo Lee, Richard P Bazinet, Ruth Seemann, Stanley I Rapoport.   

Abstract

RATIONALE AND
OBJECTIVES: Signal transduction involving the activation of phospholipase A2 (PLA2) to release arachidonic acid (AA) from membrane phospholipids, when coupled to dopamine D1- and D2-type receptors, can be imaged in rats having a chronic unilateral lesion of the substantia nigra. It is not known, however, if the signaling responses occur in the absence of a lesion. To determine this, we used our in vivo fatty acid method to measure signaling in response to D1 and D2 receptor agonists given acutely to unanesthetized rats.
METHODS: [1-(14)C]AA was injected intravenously in unanesthetized rats, and incorporation coefficients k* for AA (brain radioactivity/integrated plasma radioactivity) were measured using quantitative autoradiography in 61 brain regions. The animals were administered i.v. the D2 receptor agonist, quinpirole (1 mg kg(-1), i.v.), the D1 receptor agonist SKF-38393 (5 mg kg(-1), i.v.), or vehicle/saline.
RESULTS: Quinpirole increased k* significantly in multiple brain regions rich in D2-type receptors, whereas SKF-38393 did not change k* significantly in any of the 61 regions examined.
CONCLUSIONS: In the intact rat brain, D2 but not D1 receptors are coupled to the activation of PLA2 and the release of AA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163535     DOI: 10.1007/s00213-005-2208-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.

Authors:  F Bordi; E Meller
Journal:  Brain Res       Date:  1989-12-18       Impact factor: 3.252

2.  Preferential in vivo incorporation of [3H]arachidonic acid from blood in rat brain synaptosomal fractions before and after cholinergic stimulation.

Authors:  C R Jones; T Arai; J M Bell; S I Rapoport
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

3.  The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat.

Authors:  C N Haile; G Carey; G B Varty; V L Coffin
Journal:  Eur J Pharmacol       Date:  2000-01-28       Impact factor: 4.432

4.  Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/-)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI).

Authors:  Ying Qu; Lisa Chang; Justin Klaff; Andrea Balbo; Stanley I Rapoport
Journal:  Neuropsychopharmacology       Date:  2002-06-05       Impact factor: 7.853

5.  Autoradiographic analysis of dopamine receptor-stimulated [(35)S]GTPgammaS binding in rat striatum.

Authors:  L He; D A Di Monte; J W Langston; M Quik
Journal:  Brain Res       Date:  2000-12-01       Impact factor: 3.252

6.  Co-localization of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey cerebellum.

Authors:  Sibile Pardue; Stanley I Rapoport; Francesca Bosetti
Journal:  Brain Res Mol Brain Res       Date:  2003-08-19

Review 7.  A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis.

Authors:  P J Robinson; J Noronha; J J DeGeorge; L M Freed; T Nariai; S I Rapoport
Journal:  Brain Res Brain Res Rev       Date:  1992 Sep-Dec

8.  Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.

Authors:  A I Levey; S M Hersch; D B Rye; R K Sunahara; H B Niznik; C A Kitt; D L Price; R Maggio; M R Brann; B J Ciliax
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

9.  Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats.

Authors:  J J DeGeorge; T Nariai; S Yamazaki; W M Williams; S I Rapoport
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

10.  D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.

Authors:  C R Gerfen; K A Keefe; E B Gauda
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

View more
  26 in total

1.  The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.

Authors:  Madhav Thambisetty; Kathy A Gallardo; Jeih-San Liow; Lori L Beason-Held; John C Umhau; Abesh K Bhattacharjee; Margaret Der; Peter Herscovitch; Judith L Rapoport; Stanley I Rapoport
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-14       Impact factor: 6.200

2.  Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.

Authors:  Epolia Ramadan; Lisa Chang; Mei Chen; Kaizong Ma; F Scott Hall; George R Uhl; Stanley I Rapoport; Mireille Basselin
Journal:  Int J Neurosci       Date:  2012-03-26       Impact factor: 2.292

3.  Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.

Authors:  Epolia Ramadan; Mireille Basselin; Ameer Y Taha; Yewon Cheon; Lisa Chang; Mei Chen; Stanley I Rapoport
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

4.  Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography.

Authors:  Giuseppe Esposito; Giampiero Giovacchini; Margaret Der; Jeih-San Liow; Abesh K Bhattacharjee; Kaizong Ma; Peter Herscovitch; Michael Channing; William C Eckelman; Mark Hallett; Richard E Carson; Stanley I Rapoport
Journal:  Neuroimage       Date:  2006-12-29       Impact factor: 6.556

5.  Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease.

Authors:  Ho-Joo Lee; Richard P Bazinet; Stanley I Rapoport; Abesh Kumar Bhattacharjee
Journal:  Neurochem Res       Date:  2009-12-08       Impact factor: 3.996

6.  Acute nicotine reduces brain arachidonic acid signaling in unanesthetized rats.

Authors:  Lisa Chang; Stanley I Rapoport; Henry N Nguyen; Dede Greenstein; Mei Chen; Mireille Basselin
Journal:  J Cereb Blood Flow Metab       Date:  2009-01-14       Impact factor: 6.200

7.  Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions.

Authors:  R E Rao; F H E Wojnicki; J Coupland; S Ghosh; R L W Corwin
Journal:  Pharmacol Biochem Behav       Date:  2008-02-15       Impact factor: 3.533

8.  Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats.

Authors:  Abesh Kumar Bhattacharjee; Lisa Chang; Laura White; Richard P Bazinet; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2008-02-15       Impact factor: 4.530

9.  Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Authors:  Jagadeesh S Rao; Stanley I Rapoport; Hyung-Wook Kim
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 5.176

10.  Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Authors:  Abesh K Bhattacharjee; Lisa Chang; Mei Chen; Laura White; Jane M Bell; Richard P Bazinet; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.